Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02832843

Genome-Wide Association Study in Patients With Nontuberculous Mycobacterial Lung Disease

Mycobacterium Infections, Nontuberculous Clinical Trial

Official title:
Elucidation of Genetic Susceptibility of Patients With Nontuberculous Mycobacterial Lung Disease Using Genome-Wide Association Study

Clinical Trial Summary

The aim of this study was to elucidate genetic susceptibility of patients with nontuberculous mycobacterial lung disease using genome-wide association study.

Clinical Trial Description

Nontuberculous mycobacteria (NTM) are ubiquitous environmental organisms. NTM lung disease is increasing, however, genetic susceptibility of patients with the disease have not been identified. To elucidate the genetic susceptibility of NTM lung disease, the investigators perform a genome-wide association study (GWAS) including patients with NTM lung disease and healthy controls (case : control = 1 : 3). The age-, sex-matched control group will be recruited from the Korean Healthy Twin Study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02832843
Study type Observational
Source Seoul National University Hospital
Contact
Status Completed
Phase
Start date July 11, 2016
Completion date October 3, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT03038178 - Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease Phase 2
Active, not recruiting NCT04922554 - Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc) Phase 2
Terminated NCT04154826 - Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease Phase 2
Completed NCT02344004 - Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone Phase 3
Recruiting NCT06266442 - M. Avium WGS During Mav-PD Treatment
Recruiting NCT02355015 - A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections N/A
Completed NCT03421743 - Pilot Trial of Inhaled Molgramostim in Nontuberculous Mycobacterial (NTM) Infection Phase 2
Not yet recruiting NCT06418711 - ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension Phase 3
Terminated NCT03597347 - Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection Phase 2
Completed NCT04677543 - Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex Phase 3
Completed NCT02340897 - Diagnostic Accuracy of Nontuberculous Mycobacterial Lung Disease Based on Chest CT N/A
Completed NCT01315236 - Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria Phase 2
Recruiting NCT04677569 - Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex Phase 3